The Call for Opposition: Challenging the P2P and IOM Processes
In our second article on how to react to the publication of the draft P2P report, Gabby Klein provides her view of why she and a large group of advocates and patients are continuing their protest of the government’s ongoing control and manipulation of our disease via their processes...
Discuss the article on the Forums.

Hemispherx Biopharma Announces Plans to File for Regulatory Approval of Ampligen®

Discussion in 'General ME/CFS News' started by JohnnyD, Mar 10, 2014.

  1. JohnnyD

    JohnnyD Senior Member

    Messages:
    154
    Likes:
    250
    Hemispherx Biopharma Announces Plans to File for Regulatory Approval of Ampligen® to Treat Chronic Fatigue Syndrome (CFS) in Three Additional Latin America Countries

    …New Trademarks now approved

    Philadelphia, PA, March 10, 2014: Hemispherx Biopharma, Inc. (NYSE Amex: HEB) (the "Company” or "Hemispherx”), announced that it and its partner in Latin America, GP Pharm, are planning on making applications in Chile, Peru and Uruguay for regulatory approval of Ampligen® to treat CFS.

    Jorge Braver, President of GP Pharm, said "In Latin American countries, in order to file for regulatory approval of a product, companies must first gain clearance of the trademarks in each country. We have now received notification of clearance of the trademark "Rintamod” (Ampligen® in the US) in these three countries and are now planning on making the filings for regulatory approval.”

    Thomas K. Equels, Executive Vice Chairman of Hemispherx, said, "This is our next step in Hemispherx’s global strategy for Ampligen® following our July 18, 2012 announcement regarding a filing for regulatory approval of Ampligen® (‘Rintamod’) to treat CFS in Argentina.”
     
  2. minkeygirl

    minkeygirl Senior Member

    Messages:
    2,725
    Likes:
    1,934
    Left Coast
    Fantastic news!!!
     
  3. Iquitos

    Iquitos Senior Member

    Messages:
    511
    Likes:
    937
    Colorado
    Wouldn't it be something if we could get treatment for this disease by moving to Latin America! I wonder how much it's going to cost there -- IF it gets approval. They tend to follow the US FDA in this sort of thing.
     

See more popular forum discussions.

Share This Page